Srinath Thirumalairajan
Executive Director, CMC Callio Therapeutics
Seminars
Tuesday 13th October 2026
From Complexity to Manufacturability: Considerations to Rapidly Develop & Manufacture Dual Payload ADCs
12:00 pm
- Exploring an AI-enabled, modular, antibody-agnostic linker platform to enable reproducible manufacturing of scalable dual payload ADCs
- Laying out considerations for rapid development and manufacturing of novel dual payload ADCs while maintaining cost efficiency comparable to single payload ADCs
- Demonstrating proven manufacturability and developability across multiple dual-payload ADCs
Tuesday 13th October 2026
Panel Discussion: Building the Next Generation of ADC Linkers & Payloads: What do Innovators Need from Development & Manufacturing Partners?
5:45 pm
- Discussing the scientific, technical, and strategic factors that drive ADC program success, spanning established linkers and payloads as well as emerging ADC mechanisms and designs
- Exploring how development and manufacturing partners can evolve to support the changing needs of both large pharmaceutical companies and emerging biotech organizations as ADC innovation accelerates and oncology applications expand
- Exploring evolving development and manufacturing requirements, key innovation challenges, and how partnerships can help accelerate the next generation of impactful ADC therapeutics
Wednesday 14th October 2026
Enhancing ADC Quality Characterization & Process Control to Rapidly & Confidently Produce Complex Conjugates
